DENTSPLY SIRONA (NASDAQ:XRAY – Get Free Report) and CONMED (NYSE:CNMD – Get Free Report) are both medical companies, but which is the superior stock? We will contrast the two businesses based on the strength of their dividends, analyst recommendations, profitability, earnings, risk, institutional ownership and valuation.
Valuation & Earnings
This table compares DENTSPLY SIRONA and CONMED”s top-line revenue, earnings per share (EPS) and valuation.
Gross Revenue | Price/Sales Ratio | Net Income | Earnings Per Share | Price/Earnings Ratio | |
DENTSPLY SIRONA | $3.79 billion | 0.69 | -$910.00 million | ($4.74) | -2.78 |
CONMED | $1.31 billion | 1.18 | $132.42 million | $3.53 | 14.17 |
Analyst Ratings
This is a summary of recent ratings and recommmendations for DENTSPLY SIRONA and CONMED, as provided by MarketBeat.
Sell Ratings | Hold Ratings | Buy Ratings | Strong Buy Ratings | Rating Score | |
DENTSPLY SIRONA | 0 | 11 | 2 | 0 | 2.15 |
CONMED | 0 | 4 | 1 | 0 | 2.20 |
DENTSPLY SIRONA presently has a consensus price target of $18.64, indicating a potential upside of 41.61%. CONMED has a consensus price target of $59.80, indicating a potential upside of 19.53%. Given DENTSPLY SIRONA’s higher possible upside, analysts clearly believe DENTSPLY SIRONA is more favorable than CONMED.
Volatility & Risk
DENTSPLY SIRONA has a beta of 0.96, suggesting that its stock price is 4% less volatile than the S&P 500. Comparatively, CONMED has a beta of 1.18, suggesting that its stock price is 18% more volatile than the S&P 500.
Insider & Institutional Ownership
95.7% of DENTSPLY SIRONA shares are owned by institutional investors. 0.5% of DENTSPLY SIRONA shares are owned by company insiders. Comparatively, 3.1% of CONMED shares are owned by company insiders. Strong institutional ownership is an indication that large money managers, hedge funds and endowments believe a stock is poised for long-term growth.
Dividends
DENTSPLY SIRONA pays an annual dividend of $0.64 per share and has a dividend yield of 4.9%. CONMED pays an annual dividend of $0.80 per share and has a dividend yield of 1.6%. DENTSPLY SIRONA pays out -13.5% of its earnings in the form of a dividend. CONMED pays out 22.7% of its earnings in the form of a dividend. Both companies have healthy payout ratios and should be able to cover their dividend payments with earnings for the next several years. DENTSPLY SIRONA has increased its dividend for 13 consecutive years. DENTSPLY SIRONA is clearly the better dividend stock, given its higher yield and longer track record of dividend growth.
Profitability
This table compares DENTSPLY SIRONA and CONMED’s net margins, return on equity and return on assets.
Net Margins | Return on Equity | Return on Assets | |
DENTSPLY SIRONA | -25.85% | 16.33% | 5.60% |
CONMED | 8.31% | 14.43% | 6.05% |
Summary
CONMED beats DENTSPLY SIRONA on 9 of the 17 factors compared between the two stocks.
About DENTSPLY SIRONA
DENTSPLY SIRONA Inc. manufactures and sells various dental products and technologies worldwide. It operates in four segments: Connected Technology Solutions, Essential Dental Solutions, Orthodontic and Implant Solutions, and Wellspect Healthcare. The company offers dental equipment comprising imaging equipment, motorized dental handpieces, treatment centers, other instruments, amalgamators, mixing machines, and porcelain furnaces; and dental CAD/CAM technologies to support dental restorations, such as intraoral scanners, 3-D printers, mills, other software and services, and a full-chairside economical restoration of esthetic ceramic dentistry, as well as DS Core, its cloud-based platform. It also provides endodontic products consisting of motorized endodontic handpieces, files, sealers, irrigation needles, and other tools that support root canal procedures; restorative products, including dental ceramics, crowns, and veneers; and preventative products, such as curing light systems, dental diagnostic systems, and ultrasonic scalers and polishers, as well as dental anesthetics, prophylaxis paste, dental sealants, and impression materials. In addition, the company offers SureSmile and Byte aligner solutions; VPro/HyperByte, a high-frequency vibration technology device; SureSmile Simulator, which creates a 3D visualization of a patient's outcome; and Byte Plus for treatment planning. Further, it provides dental implants, digital dentures, crown and bridge porcelain products, bone regenerative and restorative solutions, treatment planning software, and educational programs; dental prosthetics; urology catheters; and other health-related consumables. The company serves professional dental and consumable medical device markets through third-party distributors. The company was formerly known as DENTSPLY International Inc. and changed its name to DENTSPLY SIRONA Inc. in February 2016. DENTSPLY SIRONA Inc. was founded in 1877 and is headquartered in Charlotte, North Carolina
About CONMED
CONMED Corporation, a medical technology company, develops, manufactures, and sells surgical devices and related equipment for surgical procedures worldwide. The company offers orthopedic surgery products, including BioBrace, TruShot with Y-Knot All-In-One Soft Tissue Fixation System, Y-knot All-Suture Anchors, and Agro Knotless Suture Anchors, which provide clinical solutions to orthopedic surgeons for the augmentation and repair of soft tissue injuries, as well as provides supporting products that enable surgeons to perform minimally invasive sports medicine surgeries. It markets orthopedic surgery products under the Hall, CONMED Linvatec, Concept, and Shutt brands. The company also provides battery-powered and autoclavable bone power tool systems for use in orthopedic, arthroscopic, oral/maxillofacial, podiatric, spinal, and cardiothoracic surgeries under Hall surgical brand name. In addition, it offers general surgery products, including clinical insufflation systems under AirSeal brand; smoke removal devices under Buffalo Filter brand; endomechanical products, such as tissue retrieval bags, trocars, suction irrigation devices, graspers, scissors, and dissectors used in minimally invasive surgeries; and electrosurgical solution comprising monopolar and bipolar generators, argon beam coagulation generators, handpieces, smoke management systems and other accessories. Further, the company provides endoscopic technologies, including therapeutic and diagnostic products for use in gastroenterology procedures, and products for the treatment of diseases of the dilatation, hemostasis, biliary, structure management, and infection prevention and patient monitoring, including ECG and EEG electrodes, and cardiac defibrillation pads. It markets its products directly to hospitals, surgery centers, and other healthcare institutions, as well as through medical specialty distributors. CONMED Corporation was incorporated in 1970 and is headquartered in Largo, Florida.
Receive News & Ratings for DENTSPLY SIRONA Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for DENTSPLY SIRONA and related companies with MarketBeat.com's FREE daily email newsletter.